Skip to main content
. 2017 Nov 6;8(60):102244–102253. doi: 10.18632/oncotarget.22288

Table 1. Baseline characteristics of the included studies.

Study Year Design Time Period Geography Group No. Gender (M) Age (y)* Quality
Thornton [8] 2002 Retro NA 1997.07–2001.03 Ireland PEG 11 NA NA 7
PRG 25 NA NA
Chio [9] 2004 Retro 2 m 2000.10–2002.12 Italy PEG 25 13 65.1 ± 10.3 7
PRG 25 12 68.9 ± 9.5
Desport [6] 2005 Pros NA 1999.03–2002.11 France PEG 30 12 65.7 ± 10.3 6
RIG 20 4 66.1 ± 9.7
Shaw [12] 2006 Retro NA 1998.11–2003.11 UK PEG 18 9 62 (26–85) 5
RIG 72 38 60 (31–86)
Blondet [7] 2010 Retro NA 1999–2005 France PEG 18 6 66.2 ± 11.2 3
PRG 22 11 66 ± 12
Allen [10] 2013 Retro NA 2009.01–2012.03 USA PEG 57 35 59.7 ± 11.6 8
RIG 51 29 59.0 ± 11.3
PEG 163 90 64.2 ± 11.7 9
RIG 121 62 63.6 ± 9.8
ProGas Study Group [5] 2015 Pros 12 m 2010.11–2014.01 UK PRG 43 25 67.2 ± 12.6

y, year; Retro, retrospective; Pros, prospective; NA, not applicable; m, month; M, male; PEG, Percutaneous Endoscopic Gastrostomy; PRG, Per-oral Image-Guided Gastrostomy; RIG, Radiologically Inserted Gastrostomy.